Opportunities in drug development
New fellowships help pharmacists make the leap from practice to drug development
In collaboration with global leader in model-informed drug development Certara, the Faculty has announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships: Dr. Katrina Hui, Dr. Yu-Wei Lin, and Dr. Zheng Liu.
The fellowship program is designed by Monash University and Certara to help prepare the next generation of industry-experienced drug development scientists through training in clinical pharmacology, pharmacometrics and regulatory science, providing a combination of academic coursework, hands-on industry training, international industry/academic placements, and research.
“Model-informed drug discovery and development (MID3) strategy underpins all stages of contemporary drug discovery and development programs. MID3 provides a quantitative framework to improve decision making and reduce risk, and is used by global regulators to evaluate new drug submissions,” said Leigh B. Farrell, PhD, FAICD, Senior Vice President, Commercial, at Certara.
“We are delighted to welcome our first fellows to the Certara-Monash University Industry Drug Development Fellowship Program. We have spent more than a year developing the curriculum for this new leadership program, ensuring that it contains the right mix of technical training, research, and real-world experience,” said Director of the Monash Institute of Pharmaceutical Sciences, Professor Chris Porter.